Citation only
via OpenAlex
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models
Luana Naia, Tatiana Rosado Rosenstock, Ana M. Oliveira, Sofia I. Oliveira-Sousa, Gladys L. Caldeira, Catarina Carmo, Mário Laço, Michael R. Hayden, Catarina Resende Oliveira, Ana Cristina Rego
Molecular Neurobiology · 2016 · ▲ 132 citations
Abstract
This 2016 study in Molecular Neurobiology compares the mitochondrial protective effects of resveratrol and nicotinamide in models of Huntington's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s12035-016-0048-3
- Canonical
- link ↗
- Fetched
- 2026-09-29 MST
Cite this
APA
Naia, L., Rosenstock, T.R., Oliveira, A.M., Oliveira-Sousa, S.I., Caldeira, G.L., Carmo, C., Laço, M., Hayden, M.R., Oliveira, C.R., & Rego, A.C. (2016). Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models. <em>Molecular Neurobiology</em>. https://doi.org/10.1007/s12035-016-0048-3
Vancouver
Naia L, Rosenstock TR, Oliveira AM, Oliveira-Sousa SI, Caldeira GL, Carmo C, et al. Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models. Molecular Neurobiology. 2016. doi:10.1007/s12035-016-0048-3.
BibTeX
@article{luana2016Compar,
title = {Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models},
author = {Luana Naia and Tatiana Rosado Rosenstock and Ana M. Oliveira and Sofia I. Oliveira-Sousa and Gladys L. Caldeira and Catarina Carmo and Mário Laço and Michael R. Hayden and Catarina Resende Oliveira and Ana Cristina Rego},
journal = {Molecular Neurobiology},
year = {2016},
doi = {10.1007/s12035-016-0048-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurobiology 2023
Preprint · OA
CMS121 Partially Attenuates Disease Progression in Mouse Models of Huntington’s Disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009
Open access · OA
Mouse models of Huntington's disease and methodological considerations for therapeutic trials
Expert Reviews in Molecular Medicine 2022
Citation only
Effects of lifespan-extending interventions on cognitive healthspan
Neutec Ar-Ge San ve Tic A.Ş 2020
Open access · US-GOV
Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease Receiving Donepezil, Memantine or Donepezil/Memantine Combination Therapy: Open-Labeled, Randomized, Phase IV, Superiority Study
PLoS ONE 2013
Open access · CC-BY
The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep
Universidad de Almeria 2020
Open access · US-GOV